title: Letter: is body-mass index really associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B?
authors.affiliation: Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
authors.forename: R
authors.initials: R
authors.lastname: Huang
authors.affiliation: Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
authors.forename: G
authors.initials: G
authors.lastname: Wang
authors.affiliation: Department of Laboratory Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.affiliation: Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
authors.forename: B
authors.initials: B
authors.lastname: Jia
authors.affiliation: Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.
authors.forename: C
authors.initials: C
authors.lastname: Wu
mesh_terms: D000998:Antiviral Agents; D004279:DNA, Viral; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic; D006801:Humans; D019259:Lamivudine
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral; D019259:Lamivudine